(1)
Skin Manifestations Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use for Weight Loss: A Cross-Sectional Analysis. J Pak Assoc Dermatol 2026, 36 (1), 3-9. https://doi.org/10.66344/jpad.v36i1.3221.